导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -18.72% | 976/1050 |
| 近一周 | -2.26% | 512/1104 |
| 近一月 | -3.57% | 421/1102 |
| 近一季 | -8.56% | 608/1092 |
| 近半年 | -13.91% | 864/1070 |
| 近一年 | -29.86% | 986/1018 |
| 近两年 | -15.51% | 920/926 |
| 近三年 | -50.46% | 831/834 |
| 成立以来 | -22.09% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-9.72% 993/1070 |
0.67% 688/1101 |
- - |
- - |
| 2025 | -14.27% 966/1065 |
-0.41% 820/1014 |
-12.09% 1002/1038 |
7.64% 884/1050 |
-9.04% 859/1065 |
| 2024 | -16.97% 881/1011 |
-1.34% 390/960 |
-15.17% 940/983 |
13.87% 313/991 |
-12.89% 970/1011 |
| 2023 | -17.75% 616/952 |
10.10% 116/880 |
-18.55% 871/895 |
3.04% 18/915 |
-10.98% 881/952 |
| 2022 | -13.50% 142/867 |
-23.21% 678/773 |
23.29% 4/806 |
-12.74% 442/845 |
4.70% 222/867 |
| 2021 | 24.80% 114/740 |
-5.61% 368/580 |
13.98% 256/659 |
6.56% 94/704 |
8.86% 102/740 |
| 2020 | 17.79% 386/554 |
-1.32% 194/419 |
8.99% 405/466 |
8.39% 295/517 |
1.03% 481/554 |
| 2019 | - - |
- - |
- - |
-0.24% 338/390 |
11.02% 133/410 |
| 2018 | - - |
- - |
- - |
- - |
- - |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商前沿医疗保健股票C | 0.8165 | 53.69% |
| 招商医药健康产业股票 | 2.6450 | 48.73% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 嘉实医疗保健股票 | 2.6190 | 39.05% |
| 广发医药精选股票C | 1.3103 | 38.32% |
| 前海开源公共卫生股票C | 0.4647 | 37.30% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 交银医药创新股票C | 3.0948 | 35.86% |
| 长城量化精选股票A VS. 东吴新产业精选股票A(580008) |